CommercialCoverageMedium impact
Pharmacogenetic Testing for Pain Management
Blue Cross & Blue Shield of Mississippi·MS · Pain Management, Anesthesiology, Family Medicine +5 more·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi has established a new medical policy for pharmacogenetic testing in pain management, defining coverage criteria for genetic tests that assess drug metabolism and opioid use disorder risk. The policy includes detailed background on pain management genetics but does not specify coverage determination or billing requirements.
Action Required
Immediately: Billing team should review current pharmacogenetic testing claims for pain management patients to ensure alignment with new BCBS Mississippi policy A.2.04.131. Monitor for future coverage determination updates and billing guidelines from BCBS Mississippi. Providers should document medical necessity for any genetic testing related to pain medication selection or opioid use disorder risk assessment.